Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease

NCT01453569 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

255

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Cognitive Impairment

Interventions

DRUG: Sodium oligo-mannurarate 600mg
DRUG: Sodium oligo-mannurarate 900mg
DRUG: Placebo

Sponsor

Shanghai Greenvalley Pharmaceutical Co., Ltd.

Collaborators

[object Object]